SCHEMBL872814

SCHEMBL872814

CC1C(O)CC2(C(C)C)CC12

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22878195 1.00 TSHR (0.39) TSHR
SCHEMBL29462482 1.00 TSHR (0.39) TSHR
SCHEMBL668986 1.00 TSHR (0.39) TSHR
SCHEMBL17629437 1.00 TSHR (0.39) TSHR
SCHEMBL3741642 1.00 TSHR (0.39) TSHR
SCHEMBL30105568 1.00 TSHR (0.39) TSHR
SCHEMBL31026286 1.00 TSHR (0.39) TSHR
SCHEMBL1245770 1.00 TSHR (0.39) TSHR
SCHEMBL13844559 0.73 TSHR (0.39) TSHR
SCHEMBL9193538 0.72 TSHR (0.36) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619578-A2 MODIFIED FIBRE MATERIAL Wenatex Forschung - Entwicklung - Produktion GmbH (AT) 2025-09-24 EP claimed
EP-4619459-A1 MODIFIED PU FOAM Wenatex Forschung - Entwicklung - Produktion GmbH (AT) 2025-09-24 EP claimed
US-20250113855-A1 HYDRATING AND REHYDRATING COMPOSITOIN AND PRODUCT IV THOUGHT PRODUCTS AND DESIGN CORP. 2025-04-10 US claimed
WO-2024103092-A2 MODIFIED FIBRE MATERIAL WENATEX FORSCHUNG - ENTWICKLUNG - PRODUKTION GMBH (AT) 2024-05-23 WO claimed
WO-2024103091-A1 MODIFIED PU FOAM WENATEX FORSCHUNG - ENTWICKLUNG - PRODUKTION GMBH (AT) 2024-05-23 WO claimed
WO-2022187973-A1 DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH ALLIED CORP. (CA) 2022-09-15 WO claimed
US-11380884-B2 Liquid composition for producing electrode composite material, method for producing electrode, and method for producing electrochemical element RICOH COMPANY, LTD. (JP) 2022-07-05 US claimed
EP-4013438-A1 HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP GE Nutrients, Inc. (US) 2022-06-22 EP claimed
CN-114555104-A Herbal preparation for stimulating hair growth, controlling hair loss, dandruff and infections thereof using ageratum species GE营养有限公司 2022-05-27 CN claimed
US-20210046138-A1 HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP. GE NUTRIENTS, INC. (US) 2021-02-18 US claimed
CN-101708314-A Chinese medicinal essential oil injection solution, injection and preparation method thereof UNIV PLA 2ND MILITARY MEDICAL 2010-05-19 CN claimed
EP-1073337-B1 IMPROVEMENTS IN HERBICIDES ORGANIC INTERCEPTOR PRODUCTS L (NZ) 2005-02-23 EP claimed
US-6759370-B1 HIGH ALCOHOL CONTENT PINE OIL, TALL OIL ALKALI SOAP AND FERTILIZER; FOAMING EFFECT ORGANIC INTERCEPTOR PRODUCTS LIMITED (NZ) 2004-07-06 US claimed
US-20030064948-A1 Invasomes for therapy of disorders, their preparation and use VECTRON THERAPEUTICS AG (DE) 2003-04-03 US claimed
WO-2002062316-A1 INVASOMES FOR THE TREATMENT OF DISEASE STATES, PRODUCTION AND USE THEREOF VECTRON THERAPEUTICS AG (DE) 2002-08-15 WO claimed
EP-1230917-A1 Invasomes for the therapy of illnesses, their manufacture and use Vectron Therapeutics AG (DE) 2002-08-14 EP claimed
WO-2002013840-A1 ESSENTIAL OILS AND CHEMICALLY RELATED SPECIES FOR THE TREATMENT OF INCREASED BONE RESORPTION UNIVERSITY OF BERN (CH) 2002-02-21 WO claimed
EP-1073337-A2 IMPROVEMENTS IN HERBICIDES Organic Interceptor Products Limited (NZ) 2001-02-07 EP claimed
WO-1999053764-B1 IMPROVEMENTS IN HERBICIDES ORGANIC INTERCEPTOR PRODUCTS L (NZ) 2000-01-06 WO claimed
WO-1999053764-A2 IMPROVEMENTS IN HERBICIDES ORGANIC INTERCEPTOR PRODUCTS LIMITED (NZ) 1999-10-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210046138-A1 HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP. HES1, IL36G, AGER TSHR 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.